For more than a decade, the frequent use of analgesics has been recognized to lead to daily headaches in adults. To date, no studies on the occurrence of analgesic rebound headache have been done on the pediatric population. We retrospectively reviewed all charts of patients with the diagnosis of headache seen in our pediatric headache clinic between January 1996 and May 1997. Among the 98 patients seen, 46 (47%) suffered from daily or near daily headaches; 30 of them were consuming daily analgesics. Twenty-four patients (mean age 12.1 years, and mean follow-up 6.2 months) successfully discontinued their analgesics. Twenty-two patients were also placed on amitriptyline. A significant reduction in the frequency (80%), severity (47%), and number of school days missed (74%) were seen. In conclusion, this data is comparable to previous observations reported in adults, and suggests that the daily use of analgesics might result in daily or near daily headaches in the pediatric population. Discontinuing daily analgesics, with the concomitant use of amitriptyline, is an effective treatment for analgesic rebound headache in this population. (J Child Neurol 1998;13:443-447).
Get full access to this article
View all access options for this article.
References
1.
Garcia L., Papazian O.: Headache: Home remedy therapy. Int Pediatr1987;2:129-133.
2.
Shinnar S., D'Souza BJ: The diagnosis and management of headache in children. Pediatr Clin North Am1981;29:79-94.
3.
Bille B.: Migraine in school children. Acta Paediatr Scand1962; 51(Suppl):1-151.
4.
Kudrow L.: Paradoxical effects of frequent analgesic use. Adv Neuro1982;33:335-341.
5.
Rapoport AM, Weeks RE, Sheftell FD, et al: Analgesic rebound headache: Theoretical and practical implications . Cephalalgia1985;5 (Suppl):448-449.
Mathew NT, Kurman R., Perez F.: Drug induced refractory headache—clinical features and management . Headache1990;30: 634-638.
8.
Isler H.: Migraine treatment as a cause of chronic migraine, in Rose FC (ed): Advances in Migraine Research and Therapy. New York, Raven Press , 1982, pp 159-164.
9.
Warner JS, Fenichel GM: Chronic post-traumatic headache often a myth?Neurology1996;46:915-916.
Warner JS: Analgesic rebound as a cause of hemicrania continua. Neurology1997;48:1540-1541.
13.
Lippman CW: Characteristic headache resulting from prolonged use of ergot derivatives . J Nerv Ment Dis1955;3:270-273.
14.
Saper JR, Jones JM: Ergotamine dependency. Features and possible mechanisms. Clin Neuropharmacol1986;9:244-256.
15.
Isler H.: Headache drugs provoking chronic headache: Historical aspects and common misunderstandings , in Diener HC , Wilkinson M (eds): Drug-induced Headache. Berlin, Springer-Verlag,1988, pp 87-94.
16.
Henry P., Dartigues J., Benetier M., et al: Ergotamine- and analgesic-induced headaches, in Rose FC (ed): Migraine. Proceedings of the 5th International Migraine Symposium, London, 1984. London, Basel Karger , 1985, pp 197-205.
17.
Granella F. , Farina S., Malferrari G., et al: Drug abuse in chronic headache: A clinico-epidemiological study. Cephalalgia1987;7: 15-19.
Diener HC, Dichgans J., Scholz E., et al: Analgesic-induced headache: Long-term results of withdrawal therapy. J Neurol1989;236:9-14.
20.
Baumgartner C., Wessely P., Bingol C., et al: Long-term prognosis of analgesic withdrawal in patients with drug-induced headaches. Headache1989;29:510-514.
21.
Dichgans J., Diener HC: Clinical manifestation of excessive use of analgesic medication, in Diener HC, Wilkinson M (eds): Drug-induced Headache. Berlin , Springer-Verlag, 1988, pp 8-15.
22.
Michulka D., Blanchard E., Appelbaum K., et al: The refractory headache patient-II. High medication consumption (analgesic rebound headache). Behav Res Ther1989;27:411-420.
23.
Silberstein SD , Young WB: Analgesic rebound headache. How great is the problem and what can be done?Drug Safety1995 Sep;13:133-144.
24.
Headache Classification Committee of the International Headache Society: Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia1988;8 (Suppl):1-96.
25.
Warner J.: Case histories from the Vanderbilt Headache Clinic. Headache Q1993;4:254-256.
26.
Gobel H., Hamouz V., Hansen C., et al: Chronic tension-type headache: Amitriptyline reduces clinical headache duration and experimental pain sensitivity but does not alter pericranial muscle activity readings. Pain1994;59:241-249.
27.
Rapoport AM , Sheftell FD, Weeks RE, et al: The "analgesic washout period": A critical variable in the evaluation of headache treatment efficacy. Neurology1986;36(Suppl):100-101.
28.
Gladstein J. , Holden EW, Peralta L., et al: Diagnoses and symptom patterns in children presenting to a pediatric headache clinic. Headache1993;33:497-500.
29.
Lance E., Parkes C., Wilkinson M.: Does analgesic abuse cause headaches de novo?Headache1988;28:61-62.
30.
Bowdler I., Kilian J., Ganslenn-Blumberg S.: The association between analgesic abuse and headache — coincidental or causal?, letter. Headache1988;28:494.
31.
Anthony M., Srikiatkhachom A.: Platelet 5-HT and 5-HT2 receptors in analgesic abuse headache, in Rapoport AM (ed): Scientia, Headache and Pain Management. Abstract of the 1997 Annual Scientific Meeting of the Australian Association of Neurologists with the Association of British Neurologists ; Sydney, Australia, April 29-May 2, 1997. Medical Education Network, 1997;2:30-31.
32.
Srikiatkhachorn A., Govitrapong P., Limthavon C.: Up-regulation of 5-HT2 serotonin receptor: A possible mechanism of transformed migraine. Headache1994;34:8-11.
33.
Scholtz E., Diener HC, Geiselhart S.: Drug-induced headache: Does a critical dose exist?, in Diener HC, Wilkinson M (eds): Drug-Induced Headache. Berlin , Springer-Verlag, 1988, pp 29-43.
